Diamedica Therapeutics Stock Price History
| DMAC Stock | USD 4.34 0.05 1.17% |
Below is the normalized historical share price chart for DiaMedica Therapeutics extending back to January 04, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DiaMedica Therapeutics stands at 4.34, as last reported on the 20th of October, with the highest price reaching 4.36 and the lowest price hitting 4.21 during the day.
If you're considering investing in DiaMedica Stock, it is important to understand the factors that can impact its price. DiaMedica Therapeutics appears to be slightly risky, given 3 months investment horizon. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for DiaMedica Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize DiaMedica Therapeutics' Mean Deviation of 2.67, downside deviation of 2.95, and Semi Deviation of 2.68 to check if our risk estimates are consistent with your expectations.
At present, DiaMedica Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 56.9 M, whereas Stock Based Compensation is forecasted to decline to about 876.3 K. . As of October 20, 2024, Price To Sales Ratio is expected to decline to 49.24. In addition to that, Price Earnings Ratio is expected to decline to -5.01. DiaMedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 2008 | 200 Day MA 3.2103 | 50 Day MA 4.0972 | Beta 1.478 |
DiaMedica |
Sharpe Ratio = 0.1194
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DMAC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.25 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average DiaMedica Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DiaMedica Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.4733 | Book Value 1.251 | Enterprise Value 131.9 M | Enterprise Value Ebitda (0.96) | Shares Float 26.3 M |
DiaMedica Therapeutics Stock Price History Chart
There are several ways to analyze DiaMedica Stock price data. The simplest method is using a basic DiaMedica candlestick price chart, which shows DiaMedica Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 8, 2024 | 4.65 |
| Lowest Price | August 7, 2024 | 3.25 |
DiaMedica Therapeutics October 20, 2024 Stock Price Synopsis
Various analyses of DiaMedica Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell DiaMedica Stock. It can be used to describe the percentage change in the price of DiaMedica Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of DiaMedica Stock.| DiaMedica Therapeutics Price Rate Of Daily Change | 1.01 | |
| DiaMedica Therapeutics Price Daily Balance Of Power | 0.33 | |
| DiaMedica Therapeutics Price Action Indicator | 0.08 |
DiaMedica Therapeutics October 20, 2024 Stock Price Analysis
DiaMedica Stock Price History Data
The price series of DiaMedica Therapeutics for the period between Mon, Jul 22, 2024 and Sun, Oct 20, 2024 has a statistical range of 1.4 with a coefficient of variation of 10.04. Under current investment horizon, the daily prices are spread out with arithmetic mean of 3.94. The median price for the last 90 days is 4.0. The company completed 1:20 stock split on 15th of November 2018. DiaMedica Therapeutics completed dividends distribution on 2018-11-15.| Open | High | Low | Close | Volume | ||
10/20/2024 | 4.25 | 4.36 | 4.21 | 4.34 | ||
| 10/18/2024 | 4.25 | 4.36 | 4.21 | 4.34 | 22,078 | |
| 10/17/2024 | 4.36 | 4.36 | 4.27 | 4.29 | 24,808 | |
| 10/16/2024 | 4.43 | 4.45 | 4.36 | 4.40 | 27,283 | |
| 10/15/2024 | 4.49 | 4.50 | 4.38 | 4.45 | 29,528 | |
| 10/14/2024 | 4.30 | 4.50 | 4.26 | 4.46 | 71,575 | |
| 10/11/2024 | 4.41 | 4.49 | 4.18 | 4.25 | 17,798 | |
| 10/10/2024 | 4.50 | 4.53 | 4.36 | 4.42 | 89,950 | |
| 10/09/2024 | 4.73 | 4.77 | 4.40 | 4.50 | 117,743 | |
| 10/08/2024 | 4.46 | 4.67 | 4.41 | 4.65 | 171,015 | |
| 10/07/2024 | 4.46 | 4.46 | 4.32 | 4.37 | 31,886 | |
| 10/04/2024 | 4.46 | 4.46 | 4.22 | 4.36 | 28,672 | |
| 10/03/2024 | 4.45 | 4.45 | 4.36 | 4.39 | 19,236 | |
| 10/02/2024 | 4.18 | 4.47 | 4.18 | 4.45 | 87,635 | |
| 10/01/2024 | 4.17 | 4.23 | 4.11 | 4.23 | 30,616 | |
| 09/30/2024 | 4.15 | 4.30 | 4.15 | 4.19 | 22,968 | |
| 09/27/2024 | 4.22 | 4.29 | 4.16 | 4.18 | 31,659 | |
| 09/26/2024 | 4.15 | 4.31 | 4.15 | 4.30 | 32,706 | |
| 09/25/2024 | 4.10 | 4.25 | 4.09 | 4.14 | 34,823 | |
| 09/24/2024 | 4.04 | 4.16 | 3.86 | 4.03 | 80,677 | |
| 09/23/2024 | 4.10 | 4.18 | 4.01 | 4.01 | 52,731 | |
| 09/20/2024 | 4.08 | 4.13 | 4.00 | 4.13 | 188,021 | |
| 09/19/2024 | 4.16 | 4.20 | 3.99 | 4.04 | 61,882 | |
| 09/18/2024 | 4.36 | 4.48 | 3.98 | 4.13 | 77,192 | |
| 09/17/2024 | 4.50 | 4.53 | 4.35 | 4.35 | 19,875 | |
| 09/16/2024 | 4.54 | 4.72 | 4.45 | 4.49 | 44,802 | |
| 09/13/2024 | 4.34 | 4.95 | 4.23 | 4.50 | 188,810 | |
| 09/12/2024 | 4.32 | 4.40 | 4.20 | 4.29 | 32,562 | |
| 09/11/2024 | 4.14 | 4.49 | 4.14 | 4.38 | 113,458 | |
| 09/10/2024 | 4.15 | 4.19 | 4.05 | 4.19 | 35,450 | |
| 09/09/2024 | 4.07 | 4.53 | 4.02 | 4.14 | 159,061 | |
| 09/06/2024 | 3.82 | 4.07 | 3.80 | 4.03 | 68,553 | |
| 09/05/2024 | 3.88 | 3.93 | 3.76 | 3.85 | 52,710 | |
| 09/04/2024 | 3.84 | 3.99 | 3.82 | 3.96 | 10,012 | |
| 09/03/2024 | 4.01 | 4.01 | 3.79 | 3.89 | 25,288 | |
| 08/30/2024 | 3.95 | 3.96 | 3.84 | 3.93 | 14,581 | |
| 08/29/2024 | 4.00 | 4.00 | 3.94 | 3.94 | 7,052 | |
| 08/28/2024 | 4.00 | 4.04 | 3.94 | 3.99 | 29,660 | |
| 08/27/2024 | 4.06 | 4.06 | 3.82 | 3.95 | 37,803 | |
| 08/26/2024 | 3.95 | 4.07 | 3.91 | 4.07 | 35,808 | |
| 08/23/2024 | 3.98 | 4.00 | 3.88 | 4.00 | 30,299 | |
| 08/22/2024 | 3.76 | 4.04 | 3.74 | 3.98 | 123,136 | |
| 08/21/2024 | 3.65 | 3.71 | 3.60 | 3.70 | 21,662 | |
| 08/20/2024 | 3.59 | 3.71 | 3.53 | 3.70 | 31,543 | |
| 08/19/2024 | 3.55 | 3.65 | 3.50 | 3.57 | 52,345 | |
| 08/16/2024 | 3.46 | 3.60 | 3.46 | 3.60 | 15,627 | |
| 08/15/2024 | 3.50 | 3.60 | 3.43 | 3.51 | 13,529 | |
| 08/14/2024 | 3.59 | 3.59 | 3.46 | 3.48 | 10,604 | |
| 08/13/2024 | 3.57 | 3.69 | 3.50 | 3.58 | 23,142 | |
| 08/12/2024 | 3.59 | 3.77 | 3.50 | 3.53 | 45,519 | |
| 08/09/2024 | 3.39 | 3.67 | 3.38 | 3.55 | 49,032 | |
| 08/08/2024 | 3.28 | 3.40 | 3.26 | 3.35 | 37,573 | |
| 08/07/2024 | 3.39 | 3.45 | 3.25 | 3.25 | 25,943 | |
| 08/06/2024 | 3.40 | 3.51 | 3.26 | 3.35 | 31,553 | |
| 08/05/2024 | 3.30 | 3.45 | 3.25 | 3.45 | 57,179 | |
| 08/02/2024 | 3.38 | 3.48 | 3.30 | 3.31 | 44,006 | |
| 08/01/2024 | 3.46 | 3.72 | 3.36 | 3.45 | 82,174 | |
| 07/31/2024 | 3.53 | 3.64 | 3.28 | 3.28 | 80,561 | |
| 07/30/2024 | 3.74 | 3.75 | 3.61 | 3.61 | 18,984 | |
| 07/29/2024 | 3.62 | 3.77 | 3.49 | 3.75 | 116,646 | |
| 07/26/2024 | 3.74 | 3.74 | 3.61 | 3.64 | 28,008 |
About DiaMedica Therapeutics Stock history
DiaMedica Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DiaMedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DiaMedica Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DiaMedica Therapeutics stock prices may prove useful in developing a viable investing in DiaMedica Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 32.6 M | 34.2 M | |
| Net Loss | -12.2 M | -11.6 M |
DiaMedica Therapeutics Quarterly Net Working Capital |
|
DiaMedica Therapeutics Stock Technical Analysis
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
DiaMedica Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for DiaMedica Therapeutics' price direction in advance. Along with the technical and fundamental analysis of DiaMedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DiaMedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1232 | |||
| Jensen Alpha | 0.5305 | |||
| Total Risk Alpha | 0.1091 | |||
| Sortino Ratio | 0.1325 | |||
| Treynor Ratio | (0.81) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for DiaMedica Stock analysis
When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |